Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malaria vaccine efficacy study in healthy African adult men
PACTR201202000356208Unknown
- Sponsor
- University of Oxford
- Start
- Feb 2012
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of ChAd63 ME-TRAP, MVA ME-TRAP and rabies virus inactivated antigen, A in malaria (2 arms), sponsored by University of Oxford. Primary endpoint: Time to first Plasmodium falciparum infection. Status: unknown.
02
Drugs
ChAd63 ME-TRAPMVA ME-TRAPrabies virus inactivated antigen, A
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201202000356208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201202000356208.